Summary:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SEP-4199 for the Treatment of Major Depressive Episode Associated with Bipolar I Disorder (Bipolar I Depression)
Qualified Participants Must:
Subject is 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel